Helen Milton

Nessuna posizione attualmente

Health Technology

Consumer Services

Profilo

Helen Milton formerly worked at Keryx Biopharmaceuticals, Inc., as Vice President-Global Regulatory Affairs & Quality from 2014 to 2017, AMAG Pharmaceuticals, Inc., as Senior VP-Regulatory Affairs & Quality in 2020, Mallinckrodt Pharmaceuticals, as Senior VP-Regulatory Affairs & Pharmacovigilance from 2021 to 2022, and Viridian Therapeutics, Inc., as Senior Vice President-Regulatory Affairs from 2023 to 2024.
Dr. Milton received her undergraduate degree and doctorate degree from The University of Liverpool.

Precedenti posizioni note di Helen Milton

Società	Posizione	Fine
VIRIDIAN THERAPEUTICS, INC.	Consigliere Generale	02/01/2024
AMAG PHARMACEUTICALS, INC.	Consigliere Generale	01/12/2020
KERYX BIOPHARMACEUTICALS	Consigliere Generale	01/05/2017

Vedi nel dettaglio l'esperienza di Helen Milton

Formazione di Helen Milton

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Helen Milton

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
Keryx Biopharmaceuticals, Inc. Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease	Health Technology
The University of Liverpool The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
AMAG Pharmaceuticals, Inc. AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products	Health Technology
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and manufactures monoclonal antibody products	Health Technology